These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19877024)

  • 1. Obesity, hyperlipidemia, and metabolic syndrome.
    Charlton M
    Liver Transpl; 2009 Nov; 15 Suppl 2():S83-9. PubMed ID: 19877024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity.
    Reuben A
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S13-21. PubMed ID: 11689772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant metabolic syndrome: an epidemic waiting to happen.
    Pagadala M; Dasarathy S; Eghtesad B; McCullough AJ
    Liver Transpl; 2009 Dec; 15(12):1662-70. PubMed ID: 19938136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome.
    Deedwania PC; Hunninghake DB; Bays HE; Jones PH; Cain VA; Blasetto JW;
    Am J Cardiol; 2005 Feb; 95(3):360-6. PubMed ID: 15670545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
    Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional and metabolic issues in solid organ transplantation: targets for future research.
    Ward HJ
    J Ren Nutr; 2009 Jan; 19(1):111-22. PubMed ID: 19121784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.
    Ayata G; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
    Hum Pathol; 2002 Nov; 33(11):1098-104. PubMed ID: 12454814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G; Babini M
    Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and renal transplantation.
    Merion RM; Twork AM; Rosenberg L; Ham JM; Burtch GD; Turcotte JG; Rocher LL; Campbell DA
    Surg Gynecol Obstet; 1991 May; 172(5):367-76. PubMed ID: 2028371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and liver transplantation.
    Hanouneh IA; Zein NN
    Minerva Gastroenterol Dietol; 2010 Sep; 56(3):297-304. PubMed ID: 21037547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk: prevention and treatment of the metabolic syndrome.
    Tuomilehto J
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl 2():S28-35. PubMed ID: 15953504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute renal failure after cadaveric related liver transplantation.
    Chuang FR; Lin CC; Wang PH; Cheng YF; Hsu KT; Chen YS; Lee CH; Chen CL
    Transplant Proc; 2004 Oct; 36(8):2328-30. PubMed ID: 15561239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events.
    Laryea M; Watt KD; Molinari M; Walsh MJ; McAlister VC; Marotta PJ; Nashan B; Peltekian KM
    Liver Transpl; 2007 Aug; 13(8):1109-14. PubMed ID: 17663411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and liver transplantation: a review and guide to management.
    Watt KD; Charlton MR
    J Hepatol; 2010 Jul; 53(1):199-206. PubMed ID: 20451282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of liver transplantation: diabetes mellitus.
    Pageaux GP; Faure S; Bouyabrine H; Bismuth M; Assenat E
    Liver Transpl; 2009 Nov; 15 Suppl 2():S79-82. PubMed ID: 19877023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
    Marchesini G; Bugianesi E; Forlani G; Cerrelli F; Lenzi M; Manini R; Natale S; Vanni E; Villanova N; Melchionda N; Rizzetto M
    Hepatology; 2003 Apr; 37(4):917-23. PubMed ID: 12668987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common medical diseases after liver transplantation.
    Reich D; Rothstein K; Manzarbeitia C; Muñoz S
    Semin Gastrointest Dis; 1998 Jul; 9(3):110-25. PubMed ID: 9700842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
    McTaggart RA; Terrault NA; Vardanian AJ; Bostrom A; Feng S
    Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.